Réforme de l’enseignement et pandémie SARS-CoV-2 : une équation compliquée pour nos étudiants

por Bay, Jacques-Olivier, Négrier, Sylvie
Publicado 2021

Interpreting overall survival results when progression-free survival benefits exist in today’s oncology landscape: a metastatic renal cell carcinoma case study

por Tang, Yiyun, Bycott, Paul, Åkerborg, Örjan, Jönsson, Linus, Negrier, Sylvie, Chen, Connie
Publicado 2014

Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports

por Négrier, Sylvie, Moriceau, Guillaume, Attignon, Valéry, Haddad, Véronique, Pissaloux, Daniel, Guerin, Nicole, Carrie, Christian
Publicado 2018

A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma

por Jobard, Elodie, Blanc, Ellen, Négrier, Sylvie, Escudier, Bernard, Gravis, Gwenaelle, Chevreau, Christine, Elena-Herrmann, Bénédicte, Trédan, Olivier
Publicado 2015

Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison an...

por Proskorovsky, Irina, Benedict, Agnes, Negrier, Sylvie, Bargo, Danielle, Sandin, Rickard, Ramaswamy, Krishnan, Desai, Jigar, Cappelleri, Joseph C., Larkin, James
Publicado 2018

Development and Validation of a Bedside Score to Predict Early Death in Cancer of Unknown Primary Patients

por Penel, Nicolas, Negrier, Sylvie, Ray-Coquard, Isabelle, Ferte, Charles, Devos, Patrick, Hollebecque, Antoine, Sawyer, Michael B., Adenis, Antoine, Seve, Pascal
Publicado 2009

Phase I dose-escalation study of pazopanib combined with bevacizumab in patients with metastatic renal cell carcinoma or other advanced tumors

por Négrier, Sylvie, Pérol, David, Bahleda, Rastislav, Hollebecque, Antoine, Chatelut, Etienne, Boyle, Helen, Cassier, Philippe, Metzger, Séverine, Blanc, Ellen, Soria, Jean-Charles, Escudier, Bernard
Publicado 2017

A group of novel VEGF splice variants as alternative therapeutic targets in renal cell carcinoma

por Montemagno, Christopher, Durivault, Jérôme, Gastaldi, Cécile, Dufies, Maeva, Vial, Valérie, He, Xingkang, Ambrosetti, Damien, Kamenskaya, Anna, Negrier, Sylvie, Bernhard, Jean‐Christophe, Borchiellini, Delphine, Cao, Yihai, Pagès, Gilles
Publicado 2023

Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study

por Roupret, Morgan, Brouquet, Alice, Colrat, Florian, Diez-Andreu, Pauline, Prudent, Alexis, Chartier, Mélanie, Gaudin, Anne-Françoise, Bugnard, Françoise, Chillotti, Louis, Bénard, Stève, Branchoux, Sébastien, Bellera, Carine, Negrier, Sylvie
Publicado 2023

Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma

por Cella, David, Davis, Mellar P, Négrier, Sylvie, Figlin, Robert A, Michaelson, M Dror, Bushmakin, Andrew G, Cappelleri, Joseph C, Sandin, Rickard, Korytowsky, Beata, Charbonneau, Claudie, Matczak, Ewa, Motzer, Robert J
Publicado 2014

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma

por Montemagno, Christopher, Hagege, Anais, Borchiellini, Delphine, Thamphya, Brice, Rastoin, Olivia, Ambrosetti, Damien, Iovanna, Juan, Rioux-Leclercq, Nathalie, Porta, Camillio, Negrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Pagès, Gilles, Dufies, Maeva
Publicado 2020

Circulating proteins as potential biomarkers of sunitinib and interferon-α efficacy in treatment-naïve patients with metastatic renal cell carcinoma

por Harmon, Charles S., DePrimo, Samuel E., Figlin, Robert A., Hudes, Gary R., Hutson, Thomas E., Michaelson, M. Dror, Négrier, Sylvie, Kim, Sindy T., Huang, Xin, Williams, J. Andrew, Eisen, Tim, Motzer, Robert J.
Publicado 2013

Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas

por Alhalabi, Omar, Thouvenin, Jonathan, Négrier, Sylvie, Vano, Yann-Alexandre, Campedel, Luca, Hasanov, Elshad, Bakouny, Ziad, Hahn, Andrew W, Bilen, Mehmet Asim, Msaouel, Pavlos, Choueiri, Toni K, Viswanathan, Srinivas R, Sircar, Kanishka, Albiges, Laurence, Malouf, Gabriel G, Tannir, Nizar M
Publicado 2023

Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma

por de Vries-Brilland, Manon, Rioux-Leclercq, Nathalie, Meylan, Maxime, Dauvé, Jonathan, Passot, Christophe, Spirina-Menand, Elena, Flippot, Ronan, Fromont, Gaëlle, Gravis, Gwenaelle, Geoffrois, Lionnel, Chevreau, Christine, Rolland, Fréderic, Blanc, Ellen, Lefort, Félix, Ravaud, Alain, Gross-Goupil, Marine, Escudier, Bernard, Negrier, Sylvie, Albiges, Laurence
Publicado 2023

The tyrosine-kinase inhibitor sunitinib targets vascular endothelial (VE)-cadherin: a marker of response to antitumoural treatment in metastatic renal cell carcinoma

por Polena, Helena, Creuzet, Julie, Dufies, Maeva, Sidibé, Adama, Khalil-Mgharbel, Abir, Salomon, Aude, Deroux, Alban, Quesada, Jean-Louis, Roelants, Caroline, Filhol, Odile, Cochet, Claude, Blanc, Ellen, Ferlay-Segura, Céline, Borchiellini, Delphine, Ferrero, Jean-Marc, Escudier, Bernard, Négrier, Sylvie, Pages, Gilles, Vilgrain, Isabelle
Publicado 2018

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma

por Donskov, Frede, Motzer, Robert J., Voog, Eric, Hovey, Elizabeth, Grüllich, Carsten, Nott, Louise M., Cuff, Katharine, Gil, Thierry, Jensen, Niels Viggo, Chevreau, Christine, Negrier, Sylvie, Depenbusch, Reinhard, Bergmann, Lothar, Cornelio, Izzy, Champsaur, Anne, Escudier, Bernard, Pal, Sumanta, Powles, Thomas, Choueiri, Toni K.
Publicado 2019

Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression

por Cooley, Lindsay S., Rudewicz, Justine, Souleyreau, Wilfried, Emanuelli, Andrea, Alvarez-Arenas, Arturo, Clarke, Kim, Falciani, Francesco, Dufies, Maeva, Lambrechts, Diether, Modave, Elodie, Chalopin-Fillot, Domitille, Pineau, Raphael, Ambrosetti, Damien, Bernhard, Jean-Christophe, Ravaud, Alain, Négrier, Sylvie, Ferrero, Jean-Marc, Pagès, Gilles, Benzekry, Sebastien, Nikolski, Macha, Bikfalvi, Andreas
Publicado 2021

Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma

por Oudard, Stephane, Benhamouda, Nadine, Escudier, Bernard, Ravel, Patrice, Tran, Thi, Levionnois, Emeline, Negrier, Sylvie, Barthelemy, Philippe, Berdah, Jean François, Gross-Goupil, Marine, Sternberg, Cora N., Bono, Petri, Porta, Camillo, Giorgi, Ugo De, Parikh, Omi, Hawkins, Robert, Highley, Martin, Wilke, Jochen, Decker, Thomas, Tanchot, Corinne, Gey, Alain, Terme, Magali, Tartour, Eric
Publicado 2021

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma

por Dufies, Maeva, Nollet, Marie, Ambrosetti, Damien, Traboulsi, Wael, Viotti, Julien, Borchiellini, Delphine, Grépin, Renaud, Parola, Julien, Giuliano, Sandy, Helley-Russick, Dominique, Bensalah, Karim, Ravaud, Alain, Bernhard, Jean-Christophe, Schiappa, Renaud, Bardin, Nathalie, Dignat-George, Françoise, Rioux-Leclercq, Nathalie, Oudard, Stephane, Négrier, Sylvie, Ferrero, Jean-Marc, Chamorey, Emmanuel, Blot-Chabaud, Marcel, Pagès, Gilles
Publicado 2018

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas

por Dufies, Maeva, Giuliano, Sandy, Viotti, Julien, Borchiellini, Delphine, Cooley, Linsay S, Ambrosetti, Damien, Guyot, Mélanie, Ndiaye, Papa Diogop, Parola, Julien, Claren, Audrey, Schiappa, Renaud, Gal, Jocelyn, Frangeul, Antoine, Jacquel, Arnaud, Cassuto, Ophélie, Grépin, Renaud, Auberger, Patrick, Bikfalvi, Andréas, Milano, Gérard, Escudier, Bernard, Rioux-Leclercq, Nathalie, Porta, Camillo, Negrier, Sylvie, Chamorey, Emmanuel, Ferrero, Jean-Marc, Pagès, Gilles
Publicado 2017